408 related articles for article (PubMed ID: 35362115)
1. Neuropathology of α-synuclein in Parkinson's disease.
Choong CJ; Mochizuki H
Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
[TBL] [Abstract][Full Text] [Related]
2. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
[TBL] [Abstract][Full Text] [Related]
6. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
[TBL] [Abstract][Full Text] [Related]
8. Unexpected Implication of SRP and AGO2 in Parkinson's Disease: Involvement in Alpha-Synuclein Biogenesis.
Hernandez SM; Tikhonova EB; Baca KR; Zhao F; Zhu X; Karamyshev AL
Cells; 2021 Oct; 10(10):. PubMed ID: 34685771
[TBL] [Abstract][Full Text] [Related]
9. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
10. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.
Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M
Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878
[TBL] [Abstract][Full Text] [Related]
11. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
[TBL] [Abstract][Full Text] [Related]
12. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
[TBL] [Abstract][Full Text] [Related]
13. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
[TBL] [Abstract][Full Text] [Related]
14. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
Boutros SW; Raber J; Unni VK
J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
[TBL] [Abstract][Full Text] [Related]
15. Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient.
Becerra-Calixto A; Mukherjee A; Ramirez S; Sepulveda S; Sinha T; Al-Lahham R; De Gregorio N; Gherardelli C; Soto C
Cells; 2023 Feb; 12(4):. PubMed ID: 36831291
[TBL] [Abstract][Full Text] [Related]
16. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
Saramowicz K; Siwecka N; Galita G; Kucharska-Lusina A; Rozpędek-Kamińska W; Majsterek I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203531
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Jellinger KA
Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
[TBL] [Abstract][Full Text] [Related]
20. Repetitive mild TBI causes pTau aggregation in nigra without altering preexisting fibril induced Parkinson's-like pathology burden.
Delic V; Karp JH; Guzman M; Arismendi GR; Stalnaker KJ; Burton JA; Murray KE; Stamos JP; Beck KD; Sokratian A; West AB; Citron BA
Acta Neuropathol Commun; 2022 Nov; 10(1):170. PubMed ID: 36435806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
